Project Details
| Status | Finished |
|---|---|
| Effective start/end date | 20/03/25 → 31/05/26 |
Funding
- AbbVie Inc.: £194,039.92
The clinical application of mirvetuximab in ovarian cancer - Data
- Gourley, Charlie (Principal Investigator)
| Status | Finished |
|---|---|
| Effective start/end date | 20/03/25 → 31/05/26 |